NCCN Guidelines Update: NCCN 18th Annual Conference, Advancing the Standards of Cancer CareByJune 20th 2013
Use of Personalized Medicine to Select Adjuvant Breast Cancer TherapyByAnna Azvolinsky, PhDJune 20th 2013
The Changing Landscape of Oncology: Impact for Payers and ProvidersByDawn Holcombe, MBAJune 19th 2013
Third-Party Validation of Observed Savings From an Oncology Pathways ProgramByBruce A. Feinberg, DO,Scott Milligan, PhD,Joseph Cooper, BS,Winston Wong, PharmD,Daniel Winn, MD,Neil Schneider, ASA, MAAA,Sheamus Parkes, FSA, MAAA,Jeffrey Scott, MDJune 18th 2013
I-SPY Trials Seek Effective New Drug Combinations Using Adaptive Trial DesignByBen LeachJune 18th 2013
